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 Autophagy is an evolutionarily conserved mechanism of bulk protein and 
organelle degradation that requires the ATG class of genes. Although autophagy has been 
frequently observed in dying cells in several species, a causative role for autophagy in 
cell death has not been demonstrated. We show that inhibition of caspase-8 in mouse 
L929 fibroblast cells causes cell death with the morphology of autophagy. Autophagic 
cell death in L929 cells is dependent on ATG genes and involves the receptor interacting 
protein (RIP) and the activation of the MAP kinase kinase 7(MKK7) - Jun N-terminal 
kinase (JNK) - cJUN pathway. We also show that autophagy occurs in many primary 
human tumors including cancer of the breast, lung and pancreas. Our findings validate 
autophagic cell death and might explain the role of autophagy in development, viral 
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In 1951, Glucksmann postulated the seemingly paradoxical concept of significant cell 
death accompanying cell proliferation during development of multicellular organisms (1). 
The ability to balance timely and controlled cell death with cell multiplication is also vital 
during adult life, for example to suppress tumor growth (2).  
Types of cell death 
The three major morphological types that are common in dying cells are 
apoptosis, autophagy and necrosis (3). Apoptosis is characterized by cytoplasmic 
shrinkage, nuclear condensation and chromatin fragmentation, preservation of membrane 
integrity late into the process, early exposure of phosphatidylserine on the cell surface, 
and blebbing of the plasma membrane (4). Internucleosomal fragmentation of DNA has 
generally been considered the hallmark of apoptosis (5). The execution machinery of 
apoptosis consists of a special class of proteases called caspases (6). Autophagic cell 
death, on the other hand, is characterized by formation of vacuoles that transport 
organelles and cytoplasmic content to lysosomes for degradation (7). Cytoplasm is 
condensed with tightly packed organelles and with evidence of mitochondrial 
condensation. Nuclear features such as fragmentation are not characteristic. Cells dying 
by autophagy tend to be in clusters and phagocytes are not primarily responsible for 
clearance of the dead cells (8, 9). Necrotic death shows cell swelling, loss of membrane 
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integrity and release of cytoplasmic content to the exterior (10). Nuclear changes are 
variable and inconsistent (3). 
Thirty years of cell death research has uncovered an astounding array of cell death 
mechanisms, signaling pathways and dying cell morphologies which could occur in 
various permutations and combinations. For example, caspase activation had been  
considered to be typical of apoptosis (11). However, caspases are active in autophagic 
cells in programmed cell death of Drosophila salivary glands (12). Caspase 8 activity and 
phosphatidylserine surface exposure, seen most commonly in apoptosis, have also been 
noted in necrotic dying cells (10, 13). Furthermore, nuclear condensation has been 
observed in several instances of non-apoptotic death, albeit with different patterns of 
condensation (14, 15). An important inference is that there is no single or exclusive linear 
sequence of events to bring about death in a cell. Death receptors are thought of as one of 
two pathways to activate caspases and apoptosis. Recent work suggests that death 
receptors can activate apoptotic and non-apoptotic pathways of cell death in the same cell 
type in response to the same death stimulus (13, chapter 2). Caspases, long considered to 
be synonymous with death proteases, are neither necessary nor sufficient to cause cell 
death (16, 17). Other proteases like cathepsins can cause cell death independent of 
caspases (18).  To illustrate the evolving concepts in cell death and possible relationships 
between autophagic and apoptotic cell death (Fig. 1), it is worthwhile to consider specific 







A) Both autophagy and apoptosis occur and are responsible for PCD. 
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B) Autophagy necessary for apoptosis but not sufficient for cell death. 
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Fig.1. Possible relationships between autophagy and apoptosis in dying cells. Different 
models of dying cells reveal different relationships between autophagy and apoptosis. A) 
A single death stimulus triggers death with features of both autophagy and apoptosis. B) 
Autophagy is necessary to trigger apoptosis but not sufficient by itself for death. C) 














The salivary glands of Drosophila pupae undergo massive programmed cell death 
(PCD) beginning at 12 hours after puparium formation in response to a pulse of ecdysone 
steroid (19). Dying salivary gland cells develop large vacuoles in their cytoplasm (20). 
Smaller vacuoles with enclosed organelles are observed two hours later and by 16 hours 
after puparium formation, salivary gland autolysis is complete. Microarray analyses of 
dying salivary gland cells revealed upregulation of several classes of genes including the 
Drosophila homologues of yeast ATG genes that are responsible for starvation induced 
autophagy (21). Suprisingly, there is a requirement for caspase activity for ecdysone 
regulated programmed cell death to occur in salivary gland cells and several features of 
apoptosis are present (22). Inhibition of caspases by over-expression of the viral caspase 
inhibitor p35 prevents salivary gland PCD (20). Moreover, caspase processing of 
cytoskeletal elements and nuclear fragmentation are observed in these dying cells (23). 
Thus, both autophagy and apoptosis genes contribute to Drosophila salivary gland PCD 
(Fig. 1 A).  
An interesting model to study PCD in the context of development is the 3-D 
MCF10A mammary epithelial cell culture model which closely parallels normal 
physiology of mammary glands including lumen formation in the mammary acini ( 24, 
25). Over-expression of anti-apoptotic Bcl2 family members merely delays and does not 
prevent cell death during cavity formation (26). Morphology of the dying cells reveals 
autophagic vacuoles (26). Cell death accompanied by autophagy is also seen in primary 
mouse mammary epithelial cultures and in pre-pubertal mouse mammary glands (27, 28). 
Recent reports suggest Tumor necrosis factor related apoptosis inducing ligand (TRAIL) 
induced apoptosis via death receptor activation in the above mentioned 3-D  MCF10A 
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model requires both autophagy and apoptosis for complete cell death (29) (Fig. 1 A). 
Inhibition of either process results in partial lumen formation. 
Autophagy has been postulated to be necessary for initial steps of the apoptotic 
program in a leukemic cell line CCRF-CEMVbl in response to TNF-alpha (30). CCRF-
CEMVbl cells exhibit autophagic vacuoles before apoptotic features such as nuclear 
fragmentation appear. Also, inhibition of the early stages of autophagy by the 
Phospahaditylinositol-3 kinase (PI3K) inhibitor 3-methyladenine (3-MA) prevented 
TNF-alpha induced death. Surprisingly, enhancing autophagy in these cells did not 
enhance apoptotic death in terms of extent or time. Thus, autophagy seems to be 
necessary but not sufficient for cell death (Fig. 1 B). 
Stimulation of death receptors by FasL, TNF or TRAIL can all induce caspase 
independent cell death resembling necrosis in activated T lymphocytes and this 
mechanism of cell death requires the serine threonine kinase Receptor Interacting Protein 
(RIP) (13). Furthermore, certain features observed in these dying cells such as membrane 
blebbing have been shown to be dependent on cathepsin B (18). Therefore, even classical 
mediators of apoptosis such as the death receptors could function in alternative forms of 
cell death. It would therefore seem that death signals ensure cell death by activating one 
of two (or more) alternate pathways (Fig 1 C).  
From the lines of thought touched upon in the preceding discussion, it is clear that 
artificial classifications of cell death into stand alone entities are no longer valid. Cell 
death is probably best viewed as various overlapping and intertwining combinations of 
the same components at the sensing (death receptors, steroid receptors), mediating  (e.g. 
MAP kinase kinase pathway, DAPkinase) and executing stages (e.g. caspases, cathepsins, 
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calpains, reactive oxygen species) with the ultimate end result of death. We shall next 
consider in detail the two major mechanistic processes, namely apoptosis and autophagy, 
to elaborate on their morphology and molecular machinery. 
 
Autophagy 
Autophagy is an evolutionarily conserved mechanism of protein and organelle 
degradation that has been observed in organisms that are as different as yeast and humans 
(31). Autophagy is the process by which cytoplasmic structures are sequestered into 
vacuoles and then transported to lysosomes predominantly for degradation (7). Although 
frequently observed in dying cells as discussed above (32, 33), autophagy was first 
observed as part of a hepatocellular response to lack of nutrients. Formation of 
autophagic vacuoles was described in rat liver tissue following amino acid deprivation 
and glucagon stimulation (34, 35). Autophagy is a general term that encompasses an 
ever-increasing list of related yet sufficiently distinct processes (36). 
A) Macroautophagy:  It involves formation of a double or multi membrane 
cytoplasmic vesicle-like structure that sequesters cytoplasmic proteins or 
organelles. In a series of steps detailed below, this structure is transported to the 
lysosome. The outer membrane of the structure fuses with the lysosomal limiting 
membrane, releasing the contents into the lysosome where they are degraded by 
the action of lysosomal hydrolytic enzymes. 
B) Microautophagy: The distinctive feature of this process is the outpouching of a 
portion of the lysosomal membrane to engulf an organelle. Unlike in 
 
7 
macroautophagy, there is no sequestering double membrane formed in the 
cytoplasm.  
C) Cytoplasm-to-vacuole targeting pathway (cvt): In S.cerevisiae, the biosynthetic 
physiological function of delivering the enzymes aminopeptidase I and alpha-
mannosidase to the yeast vacuole is carried out by the autophagy-like Cvt 
pathway. Several of the gene products required for the process are shared with the 
macroautophagy pathway. 
D) Pexophagy and mitophagy: The selective sequestration or engulfment of 
peroxisomes and mitochondria respectively and delivery to lysosomes. 
The best characterized type and that which is associated with dying cells is 
macroautophagy. Henceforth, the term ‘autophagy’ will refer to macroautophagy unless 
indicated otherwise.  
 
Stages in the formation of Autophagic vacuoles 
While there is no precise delineation of the stages in the process or their terminology, the 
following sequence, based on studies in S.cerevisiae, is widely accepted (7). 
1. Induction:  Autophagy inducing signals such as a lack of nutrients stimulate 
formation of a crescent shaped cisterna called the ‘phagophore’. The origin of the 
cisterna and its membranes is unknown although an endoplasmic reticulum origin 
is considered most probable (37).  
2. Formation: Elongation and complete encircling to form the double membrane 
bound ‘autophagosome' or ‘autophagic vacuole’.  
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3. Docking and fusion: Fusion of the autophagosome with a lysosome, whereupon 
the inner membrane and its enclosed cytoplasmic contents (called the ‘autophagic 
body’) are released into the lumen of the lysosome. 























A           B 
  
 
Fig.2. Stages of Autophagy in yeast. A. Autophagy commences with induction of a 
‘phagophore’ that encircles and sequesters organelles and cytoplasm to form the 
‘autopaghosome’ which then docks and fuses with a lysosome, and releases its contents 
into the lysosomal interior as the ‘autophagic body’. Lysosomal hydrolases and proteases 
ensure degradation of the autophagic body (modified from 7). B. Transmission Electron 
Microscope view of an autophagic vacuole (arrow) in a L929 mouse fibroblast cell. 
Magnification is 16000. 
















Molecular pathways and regulation of autophagy  
Genetic screens for defects in the formation of autophagic vacuoles and protein 
degradation in S.cerevisiae resulted in a better understanding of autophagy at the 
molecular level and the identification of a class of genes called ATG/APG/AUT/CVT  in 
S.cerevisiae (38, 39, 40). Yeast lacking ATG genes show defects in autophagy in 
response to starvation. Homologues for twelve yeast ATG genes and their proteins have 
been identified in other species including humans (Table 1). Several of the ATG genes are 
postulated to participate in a pair of ubiquitin-like conjugation systems (41, 42). 
It is not surprising, given the manifold functions of autophagy, that the upstream 
pathways are diverse and range from nutrient regulation, cell proliferation, cell size 
regulation, development and cell death (43).The prominent regulating molecules in 
mammalian cells are Class I and Class III PI3K, Akt-PTEN-TSC1/2-Rheb-mTOR circuit, 
the Insulin Receptor and downstream targets. Briefly, Class I PI3K, Akt, Rheb and 
mTOR components inhibit autophagy while Class III PI3K, PTEN and TSC1 and 2, and 
the mTOR inhibitor rapamycin positively regulate autophagy. It is interesting that several 
of these molecules (for example, PI3K) also regulate apoptosis, proliferation, growth, 
protein translation and cell survival. Indeed, autophagy seems to be one node in a 




























Table 1. Presumed Atg proteins in S.cerevisiae ,C.elegans, D.melanogaster  
         and Homo sapiens  (from 7). Many of the Atg proteins are conserved across  





























































































Apoptosis is characterized by exposure of phosphatidylserine on the cell surface, 
preservation of membrane integrity until late in the process when the apoptotic cell 
becomes permeable to vital dyes such as DAPI, nuclear condensation  and fragmentation, 
and engulfment by scavenger phagocytes (44). Stimuli that induce apoptosis include 
growth factor or hormone withdrawal, cell lineage, abnormally persistent cells during 
development, toxic chemicals, drugs and radiation. Apoptotic stimuli trigger activation 
cascades of a special class of proteases called caspases (45). There are two distinct 
pathways of caspase activation, namely the death receptor mediated pathway and the 
mitochondrial pathway (11).  
The Death Receptor family, that includes Fas, TNFR1, and TRAIL-R1, is located 
on the plasma membrane (fig.3). Death receptors cluster together when bound to their 
respective ligands (46, 47) and recruit adaptor molecules such as Fas associated death 
domain protein (FADD) (48). Specialized domains of the adaptor molecules in turn 
recruit procaspase molecules via homotypic interactions (49). The signaling complex thus 
formed, with its constituent death receptors, adaptor molecules and procaspases, is called 
the Death Inducing Signaling Complex (DISC) (50). Procaspase molecules in the DISC 
process each other through proteolysis utilizing their feeble enzymatic activity, the so 
called ‘Induced Proximity’ model (51), resulting in active caspases. The intrinsic or 
mitochondrial pathway requires APAF , cytochrome c and ADP released from 
mitochondria to recruit procaspase 9 in the formation of the ‘apoptosome’ (52), which is 
analogous to the DISC in that it contains active caspases.  
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Caspases are cysteine containing aspartate specific proteases (45). They are 
classified into initiator caspases and effector caspases (25). The subset of caspases called 
initiator caspases (including caspase 8, caspase 9, caspase 10, caspase 2) are activated in 
response to a death inducing stimulus at the DISC or at the apoptosome.  Initiator 
caspases in turn process effector caspases. The effector caspases (including caspase 3, 
caspase 6, caspase 7) are responsible for the morphological hallmarks of apoptosis 
through their protease activity on a variety of substrates. For example, caspase-3 degrades 
the Inhibitor of Caspase Activated DNase (ICAD), thereby releasing the DNase (CAD) 
from inhibition. DNase action results in the characteristic ladder of DNA fragments 
detected in apoptotic cells (53). 
It should be mentioned that death receptors in spite of their name do not 
invariably cause cell death. For example, death receptors, adaptors like FADD and 
caspases activation has been shown to induce NF-KB expression and modulate immune 
and pro-survival responses (54, 55, 56). The polar outcomes of death receptor signaling 
are probably determined by the receptor type and domains, the identity of the adaptor 
molecules and their interacting proteins and the molecular milieu downstream. 
The focus of my thesis work has been to investigate autophagic cell death in 
mammalian cells and its relationship to apoptosis, to explore the regulatory pathways of 
autophagic death and to identify autophagy in primary human tumors. Non apoptotic cell 
death mechanisms such as autophagic cell death have wide ranging therapeutic 





















                   
    
     
 
 
Fig. 3. Death Inducing Signaling Complex (DISC). Binding of the ligand (FasL or TNF-
α) to the trimeric death receptor(TNF-R, Fas) triggers formation of the Death Inducing 
Signaling Complex (DISC) by recruitment of adaptor molecules (FADD, TRADD) via 
homotypic interactions. The DISC activates the initiator caspases caspase 8 and caspase 
10. Active caspase 8 and 10 process and activate effector caspases like caspase 3. [TNF, 
tumor necrosis factor; TNF-R1, TNF receptor type 1; TRADD, TNFR-associated death 
domain protein; FasL, Fas ligand; FADD, FAS-associated death-domain protein.] 
 
Death Domain (DD) 
Death Effector Domain (DED) 






Regulation of an Atg7-Beclin 1 Program of Autophagic Cell Death by 
Caspase-8 
 
Section 2.1: Abstract 
Caspases play a central role in apoptosis, a well-studied pathway of programmed cell 
death. Other programs of death potentially involving necrosis and autophagy may exist, 
but their relationship to apoptosis and mechanisms of regulation remain unclear. We 
define a new molecular pathway in which inhibition of caspase-8 activity induces cell 
death with the morphology of autophagy. Cell death and autophagy involve the activation 
of the receptor-interacting protein (RIP, a serine-threonine kinase), MAP kinase kinase 7 
(MKK7), Jun N-terminal kinase (JNK) and c-JUN, and are dependent on the genes ATG7 
and BECLIN-1.  Therapies involving caspase inhibitors, presently in development for a 
range of clinical conditions, may arrest apoptosis but may have the unanticipated effect of 
promoting autophagic cell death. 
 
Section 2.2: Introduction 
Apoptosis is a well-studied pathway of programmed cell death conserved from C.elegans 
to humans (57).  Caspases, a family of cysteine containing aspartate specific proteases, 
produce the morphological changes associated with apoptotic death (58, 59).  Non-
apoptotic forms of cell elimination include those with features of necrosis and autophagy 
(3, 13, 60, 61).  Necrosis can result when cell metabolism and integrity are compromised 
by a non-physiological insult.  Recently, evidence has emerged that death receptors and 
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RIP can induce caspase-independent cell death that appears necrotic (13, 61).  Autophagy 
promotes a cell survival response to nutritional starvation involving membrane-bound 
vacuoles that target organelles and proteins to the lysosome for degradation  (7, 62).  Two 
pathways containing ubiquitin-like genes that are highly conserved from yeast to humans, 
function in autophagy (ATG genes).  Certain examples of cell death have autophagic 
features, but a role for ATG genes in cell death has not been established (31). Here we 
show that autophagy is associated with death of some mammalian cells, that this death 
depends on the expression of genes that are homologous to yeast ATG genes, and that this 
mechanism of cell death is negatively regulated by caspase 8. 
 
Section 2.3: Materials and Methods 
Tissue Culture 
The mouse L929 cell line was obtained from the American Type Culture Collection 
(Rockville, MD). L929 cells were cultured in Dulbecco's modified Eagle's medium with 
4.5 g/L glucose. Media were supplemented with 2 mM L-glutamine, 1% 
penicillin/streptomycin solution, and 10% fetal bovine serum (FBS).  
Preparation of siRNA  
Non-specific RNAi oligoribonucleotides and RNAi oligoribonucleotides corresponding 
to the following cDNA sequences were purchased from Dharmacon (Boulder, CO). 
CAGTTTGGCACAATCAATA for BECLIN 1.  
GTTTGTAGCCTCAAGTGTT for mouse ATG7.  
CCACTAGTCTGACTGATGA for RIP. 
TGAGATACTCGAGGTGGAT for MKK7. 
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CATTCGATCTCATTCAGTA for c-Jun.  
GATCGAGGATTATGAAAGA for caspase-8. 
Transfection of siRNA 
0.5 nmol RNAi were transfected by Amaxa nucleofectionTM (Gaithersburg, MD). Cells 
were then cultured in growth medium for 96 hrs before further analysis.  
Cell death analysis 
Cell viability was determined after treatments by staining with propidium iodide (2 
µg/mL) and flow cytometric analysis on a FACScan.  Percent cell death was quantitated 
as previously described (63).  [Note: The above experiments were done by Yu, L] 
Electron microscopy analyses 
Cells were fixed in 3% glutaraldehyde in 0.1 M MOPS buffer (pH 7.0) for at least 16 
hours at 4oC, post-fixed in 1% osmium tetroxide for 1 hour, embedded in Spurr's resin, 
sectioned, double stained with Uranyl acetate and Lead citrate, and analyzed using a 
Zeiss EM 10 transmission electron microscope.  For each treatment or control group, at 
least 100 cells from randomly chosen transmission electron microscopy fields were 
analyzed for quantification of morphological features.  Cells with ≥ 10 vacuoles were 
scored as autophagy positive.  Statistical analysis of zVAD and DMSO treated groups 
were done with Statview 5.0.1 program. 
 
Section 2.4: Results 
zVAD, a caspase inhibitor, induces cell death in L929 cells. 
In mouse L929 fibroblastic cells, tumor necrosis factor (TNF), oxidants, ceramide, and 
radiation can induce caspase-independent death (64).  However, benzyloxycarbonyl-
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Valyl-Alanyl-Aspartic-acid (O-methyl)- fluoromethylketone (zVAD), a pan-caspase 
inhibitor with broad specificity, induced the death of L929 cells (Fig. 4).  Death began 12 
hours after zVAD treatment and was complete by 40 hours (Fig.5).  The dead cells 
appeared to be round, detached (Fig. 4 b), and had a convoluted plasma membrane 
permeable to vital dyes (Fig. 4 d); this differed from apoptosis in which nuclei are 
condensed and membrane integrity is preserved.  
Transmission electron microscopy (TEM) revealed intact mitochondria and 
endoplasmic reticulum, condensed osmophilic cytoplasm, and numerous large 
cytoplasmic inclusions that were membrane-bound vacuoles characteristic of autophagy 
(Fig. 6). A time course revealed that vacuolated cells accumulated prior to cell death (Fig. 
5 and 7). Similar results were obtained in human U937 monocytoid cells and mouse 






















Fig.4. zVAD induces cell death in L929 cells. L929 cells were treated with 1ul DMSO 
vehicle (panels a and c) or 20 uM zVAD (panels b and d) for 24 hours and then examined 
by light microscopy (panels a and b) or DAPI-staining and fluorescent microscopy 













Fig.5. Time course of zVAD induced cell death in L929 in hours (h).Cells were 
harvested, stained with propidium iodide, and cell loss was quantified by flow cytometry. 



































Fig.6. TEM analysis of L929 cells treated with zVAD. L929 cells were treated for 12 
hours with vehicle (a) or zVAD (b-d). For (c, d), early membrane-bound vacuoles (black 
arrowheads) and later vacuoles (asterisks) are shown.  Scale bars in (a, b) are 1 um and in 



























Fig.7. Autophagy precedes cell death and increases temporally in zVAD treated 
L929 cells. L929 cells were treated with 20uM zVAD and were harvested at different 
time points as indicated and analyzed for TEM for autophagic structures. % Autophagic 




Inhibition of Autophagy prevents zVAD induced cell death. 
 
The association of autophagic vacuoles with cell death has been observed in developing 
animals, but it has not been clear if it was a process to rescue or condemn the cell (8).  
Drosophila cells manifesting autophagy and death have increased ATG gene transcripts 
(21, 66), but there is no known requirement for ATG genes in any model of cell death. 
We sought evidence that autophagy was required for cell death by treating L929 cells 
with two inhibitors of autophagy, 3-methyladenine (3-MA) and Wortmannin (7, 30).  
Both inhibitors prevented zVAD-induced cell death (Fig.8).  However, these inhibitors 
are general phosphatidylinositol-3 kinase (PI-3 kinase) inhibitors and could 
simultaneously affect autophagy and other cellular processes.  
We tested whether ATG genes were required for cell death. ATG7 (HsGSA7 / 
mAPG7) is an important autophagy gene encoding a protein resembling an El-type 
ubiquitin-activating enzyme that is used in both ubiquitin-like pathways required to form 
autophagic vacuoles in yeast (67, 68).  We reduced expression of ATG7 by RNAi and 
found that zVAD-induced cell death was almost completely inhibited (Fig. 9 A).  
Another ATG gene, BECLIN-1, the mouse homolog of yeast  ATG6, encodes a Bcl-2-
interacting, candidate tumor suppressor and antiviral protein  (69, 70).  Molecular 
alterations in beclin 1 are common in human cancers and  BECLIN-1 gene knockouts in 
mice cause a dramatic increase in epithelial and hematopoietic malignancies (71, 72).  
Reduction of the Beclin-1 protein by RNAi also decreased zVAD-induced death (Fig. 9 
A). TEM analyses of cells with reduced Atg7 or Beclin-1 protein levels showed a parallel 
inhibition of autophagic vacuole formation associated with reduced cell death (Fig. 9 B) 






Fig.8. Inhibitors of autophagy prevent zVAD induced cell death. L929 cells were 
pretreated with 1 ug/ml Wortmannin (WM) or 10 mM 3-methyladenine (3-MA) for 1 
hour, then with 20 uM zVAD for 36 hrs, after which cell loss was quantitated. [Note: 



































Fig.9.  zVAD induced cell death and autophagy requires Atg7 and Beclin-1. A) Cells 
were treated with zVAD or vehicle for 36 hour, 96 hours after transfection with RNAi or 
non-specific oligonucleotides. The % cell loss (solid bars) and the fraction of cells with 
autophagy features (>10 autophagic vacuoles/cell) based on TEM (open bars) were 
quantitated.  All quantitative data represent at least 3 experiments. The steady state levels 
of the corresponding proteins are shown by Western blot (inset). B) TEM of L929 cells 
transfected with ATG RNAi and treated with zVAD. Representative TEM of L929 cells 
transfected RNAi as indicated or non-specific oligonucleotides. After 96 hours, these 






































RNAi of RIP prevents zVAD induced cell death. 
Death receptors can elicit nonapoptotic death through the ‘receptor-interacting protein’ 
(RIP), a death-domain-containing, serine-threonine kinase (13, 61).  We therefore 
reduced RIP expression by RNAi and observed decreased autophagy and decreased cell 
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Fig.10. zVAD induced cell death and autophagy require RIP. A) L929 cells were treated 
with zVAD or vehicle 96 hours after transfection with RIP RNAi or non-specific 
oligonucleotides and the % cell loss (solid bars) and the fraction of cells with autophagy 
features based on TEM (open bars) was quantitated. The steady state level of RIP is 
shown by Western blot (inset). B) TEM of L929 cells transfected with RIP RNAi and 
treated with zVAD. L929 cells were transfected with non specific oligonucleotides or 
RIP RNAi. After 96 hours, these cells were treated with zVAD for 36 hours. Scale bars in 
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JNK Inhibitor II, RNAi of MKK7 and c-Jun prevent zVAD induced Cell Death.   
 
zVAD activated c-Jun N-terminal kinase (JNK) which is also activated by RIP in 
response to cytokines (73). Moreover, a JNK inhibitor, but not inhibitors against p38 or 
Erk, blocked zVAD-induced cell death, further indicating a specific role for JNK (Fig. 
11).  The protein synthesis inhibitor cycloheximide (CHX) blocked cell death, indicating 
that protein synthesis was required (Fig. 11).  
RNAi silencing of the JNK-activating kinase MAP kinase kinase 7 (MKK7) also 
completely prevented cell death and formation of autophagic vacuoles (Fig. 12 A and B).  
RNAi suppression of the transcription factor c-Jun reduced but did not eliminate the c-
Jun protein and inhibited autophagy and cell death by 45 to 50% (Fig. 12 A).  Thus, a 
signal pathway involving RIP, MKK7, JNK, and c-Jun appears to activate autophagy and 
cell death.  The involvement of c-Jun and new protein synthesis implies transcription of 





























Fig.11. JNK inhibitor and Cycloheximide prevent zVAD induced cell death. zVAD-
induced cell death in cells treated with control, JNK inhibitor II (1ug/ml), or 
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        NS RNAi       MKK7 RNAi          c-JUN RNAi 
Fig.12. zVAD induced Cell Death and Autophagy require the JNK Pathway. A) Cells 
were treated with zVAD or vehicle 96 hours after transfection with MKK7 RNAi, c-Jun 
RNAi, or non-specific oligoribonucleotides. The % cell loss (solid bars) and the fraction 
of cells with autophagy features (>10 autophagic vacuoles/cell) on TEM (open bars) were 
quantitated. The steady state level of the corresponding proteins is shown by Western blot 







































Caspase-8 RNAi induces Cell Death. 
Finally, we addressed how zVAD induced autophagic cell death.  Active caspase-8 
functions in lymphocyte receptor signaling pathways that do not cause cell death (74).  
We therefore used RNAi to progressively reduce caspase-8 expression over time and 
found that cell death was correspondingly increased (Fig. 13 A).  Cells in which caspase-
8 was reduced showed features of autophagy (Fig. 13 B). Because zVAD is a potent 
















       
 
 








Fig.13. Downregulation of caspase 8 induces cell death. A) Time course of viability of 
L929 cells transfected with either nonspecific (NS) (open symbol) or caspase-8-specific 
(solid symbol) RNAi at 24, 96, 110 hrs after transfection. Panels below show the 
abundance of caspase-8 protein by Western blot [done by Yu,L] B) Representative TEM 
pictures and quantification of the cells treated with either nonspecific or caspase-8-
specific RNAi s. Cells were harvested at 96 hrs after RNAi transfection. (a) NS control 
cell, (b-d) caspase-8 RNAi at different magnifications.  Scale bars in a and b, 1 uM, c and 
d, 0.5 uM. Arrowheads indicate double membrane autophagic vacuoles. (e) The fraction 
of cells with autophagic features based on TEM was quantified (for NS vs. Caspase-8, 






Extent of autophagy correlates with cell death. 
As mentioned above, zVAD treated L929 cells had significantly more autophagy 
compared to  control DMSO treated cells as measured by both morphometric analysis 
and number of autophagic vacuoles compared (for DMSO control vs. 8 hour or 12 hour 
zVAD treated, p<0.0001, Mann-Whitney U test). Inhibition of ATG7 or BECLIN-1 by 
RNAi prevented formation of autophagic structures as determined by TEM (for NS vs.  
ATG7 or BECLIN-1, P<0.000.1, Mann-Whitney U test). Similarly, inhibition of RIP, 
MKK7 and c-JUN  by RNAi before zVAD treatment decreased the number of autophagic 
vacuoles significantly in all three cases (for NS vs. RIP or MKK7 or c-Jun, p<0.0001, 
Mann-Whitney U test). Finally, CASPASE-8 RNAi mimicked zVAD treatment with 
respect to induction of autophagy (for NS vs. CASPASE 8 RNAi, p<0.0001, Mann-
Whitney U test).  
Section 2.5: Discussion 
We have shown that two key autophagy genes, ATG7 and BECLIN-1, are necessary for 
an autophagic death pathway in mammalian cells.  This may explain other forms of non-
apoptotic death (29).  To our knowledge, this report is the first direct evidence for an 
autophagy dependent process of cell death and one that can be blocked by inhibiting the 
ATG class of genes. The conservation of mammalian autophagic death genes in yeast 
suggests that this process might have arisen early in eukaryotic evolution. BECLIN-1 
gene knockouts cause an unexplained increase in spontaneous tumors (71, 72), and it is 
possible that Beclin 1 may act as a tumor suppressor by causing autophagic cell death.   
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We have shown a role for Caspase-8 in the regulation of autophagy. The 
suppression of autophagic death by Caspase-8 in mammalian cells indicates caspases can 
regulate both apoptotic and non-apoptotic cell death.  We favor the idea that there is a 
low constitutive level of caspase-8 activation that carries out cellular regulatory processes  
(74). Interestingly, this regulatory role is specific for Caspase-8 alone and inhibition of 
other caspases does not affect autophagy (unpublished Yu, L et al).  
Because viral pathogens have caspase inhibitors, the autophagic pathway could be 
poised to counter viral infection as a “fail-safe” mechanism. The existence of two distinct 
pathways, one activated by Caspase-8 and the other supressed by Caspase-8, might act to 
ensure cell obliteration when cell death is of paramount importance as during normal 
embryogenesis. Lastly, caspase inhibitors are currently being developed as therapeutic 
agents for neurodegenerative diseases characterized by abnormal cell death (75,76).  Our 
findings indicate that caspase inhibition could have the untoward effect of exacerbating 














Autophagy in Human tumors. Cell Survival or Death? 
 
 
Section 3.1: Introduction 
The development of tumors involves multiple genomic changes that result in abnormal 
neoplastic cells and necessary alterations in the surrounding support tissue. Similar to the 
dynamics of a developing tissue or organism, tumors can be viewed as amalgamations of 
multiple cell types of epithelial, stromal, angiogenic and connective tissue origin that are 
intricately linked by their interactions (2). Tumor growth involves two essential 
deviations from the normal state including the induction of proliferative stimuli, such as 
c-Myc and E2F, and simultaneous suppression of potentially compensatory cell death 
(77). It is well recognized that apoptosis is impaired in many cancers by mutations in 
genes such as p53 (2, 78), but it remains to be determined if non-apoptotic cell death 
mechanisms are also impaired in neoplastic cells. While compelling evidence indicates 
that aberrations in cell proliferation and death are the critical determinants of neoplastic 
growth, recent discoveries suggest that less studied mechanisms may contribute to tumor 
growth control. 
Autophagy is an evolutionarily conserved mechanism of protein and organelle 
degradation that has been observed in organisms that are as different as yeast and 
humans. Autophagy involves the sequestration of cytoplasmic structures into vacuoles 
that are transported to lysosomes for degradation (7). Recent studies of autophagy 
suggest that this mechanism of proteolysis may function in the regulation of cell survival 
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and death (79 and chapter 2). There are at least three ways in which autophagy might 
enhance cancer cell survival. Autophagy may serve to optimize nutrient utilization in 
rapidly growing cancer cells when faced with hypoxic or metabolic stress similar to the 
starvation response observed in normal cells (80). Alternatively, autophagy might aid in 
degradation of organelles such as depolarized mitochondria that activate death pathways 
(81). Autophagy might also prevent cells from accumulating free radical induced damage 
to lethal levels by removing organelles that are sources or targets of such damage. 
While the role of autophagy in cell survival during nutrient deprivation is well 
characterized, less is known about the possible role of this form of proteolysis in cell 
death even though autophagy occurs in dying cells of diverse organisms (8, 31). 
Therefore, it is important to consider the possibility that autophagy may play an 
important role in some forms of programmed cell death (chapter 2). While autophagy 
might commence as an adaptive response that sacrifices mass for homeostasis and 
enhances survival, cell death may ensue if the process is carried beyond a threshold. 
Thus, autophagy may suppress tumor growth by causing cell death, limiting cell size, or 
otherwise maintaining a low mutation rate, and decreasing the likelihood of aberrant 
growth. We initiated a morphological survey for autophagic structures in several different 
primary human tumors on account of the paucity of evidence for autophagy in cancer. 
Section 3.2: Materials and Methods 
Tissues were all obtained from surgical resection specimens, immediately fixed in 3% 
glutaraldehyde, processed, and embedded in Embed 812. Semi-thin sections were cut, 
stained with Toluidine-Blue, and examined using light microscopy to verify the presence 
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and preservation of viable neoplastic tissue. Thin-sections were stained with uranyl 
acetate-lead citrate and examined using a Zeiss EM 10 transmission electron microscope.  
Section 3.3: Results 
Autophagic structures were observed in neoplastic cells, and displayed the morphological 
features of double and multi-lamellate membrane bound vacuoles enclosing cytoplasmic 
content and organelles (Fig.14). These autophagic vacuoles were typically in the vicinity 
of the nucleus and were frequently adjacent to swirls of endoplasmic reticulum devoid of 
ribosomes. The nuclei of these cells lacked apoptotic features such as fragmentation and 
chromatin margination. Of the 12 tumors studied, 7 had evidence of autophagy including 
ganglioneuroma, infiltrating ductal carcinoma of the breast, adenocarcinoma of the lung, 
pancreatic adenocarcinoma, and pancreatic islet cell tumor. Taking into account the small 
sample size for some of the tumor types examined, it seems reasonable to expect that 


















Table 2. Survey of human tumors for autophagic structures. 
 
Tumor types with evidence of 
autophagy 




Invasisve ductal carcinoma, breast 
Adenocarcinoma, lung 
Adenoma, pituitary gland 
Adenocarcinoma, pancreas 
Islet-cell tumor, pancreas 
Medullary carcinoma, thyroid 


























structures are present in 
neoplastic cells of multiple 
types of  primary tumors.  
 
(a) Cells of a pancreatic islet 
cell tumor that display 
autophagic features and lack 
the hallmarks of apoptosis 
(arrow).  
 
(b, c) Neoplastic pancreatic 
islet cell tumors cells 
contain early stage 
multilamellate 
(arrows) and single 
membrane-bound (arrow 
head) autophagic structures. 
 
(d) Adenocarcinoma of the 
lung contains several multi-
lamellate (arrows) and 
single membrane-bound 
(arrow head) autophagic 
structures, while the nucleus 
(n) appears normal. 
 
(e) A ganglioneuroma cell 
with a normal nucleus (n) 
and mitochodria (m) 
contains multi-lamellate 
(arows) and single 
membrane-bound (arrow 
head) autophagic structures.






Section 3.4: Discussion. 
The precise role of autophagy in cancer development, progression and response to 
therapy is not understood. The recognition of Beclin-1 (Atg6), a gene that functions in 
autophagy, as a haploinsufficient tumor suppressor raises intriguing possibilities about 
the importance of autophagy in cancer (70, 71, 72). It is possible that the mechanism of 
tumor suppression is through promotion of cell death. Autophagy peaks at pre-cancerous 
stages and diminishes at the malignant stage in some rat tumor models (82), suggesting a 
tumor suppressor role. It is interesting that autophagy is regulated by some of the same 
pathways of cell growth control that are altered in tumor formation such as the PI3K 
system (83). Further, analogs of rapamycin, which stimulate autophagy by inhibiting 
mTOR have shown promise in models of tumor therapy (84, 85, 86). Rapamycins are 
thought to stabilize tumor size rather than cause marked regression, possibly indicating 
control of cell size as the mechanism. In addition, therapeutics such as tamoxifen, an 
estrogen antagonist in breast tissue, have been shown to potently induce autophagy in 
MCF7 breast cells (87), suggesting the possibility that autophagy contributes to their anti-
neoplastic activity. 
A greater understanding of the regulation of autophagy in higher animals would 
provide better targets for cancer therapies. Although many of the genes that regulate 
autophagy in yeast appear to be conserved in diverse species (31, 89), several autophagy 
genes are absent in higher animals suggesting possible differences in the regulation of 
this form of proteolysis. Autophagy is thought to be present at basal levels in most tissues 
and is regulated by the pleiotropic mTOR pathway (88). Normal cells, unlike rapidly 
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growing cancer cells, would be expected to be less sensitive to pro-autophagic stimuli 
due to minimal metabolic demands and normal activity of regulators such as PI3K and 
Akt. Therefore, it seems likely that drugs that specifically enhance autophagy would be 
of value because of their high therapeutic index. Elucidation of the pathway downstream 
of mTOR would help avoid the pleiotropic effects of this kinase. In tumors with 
deficient apoptosis and/or up-regulation of the PIK3/Akt pathway, a combinatorial 
approach that utilizes autophagy modulators in addition to other chemotherapeutic agents 
might add value to therapy efficacy (43). 
Non-apoptotic mechanisms of cell death have been largely overlooked in studies 
of cancer causation, progression and therapy. Although the variation in cell complexity 
has been recognized in tumors (2), modest progress has been made in understanding this 
aspect of cancer biology. It is important for cancer researchers to consider the presence 
and impact of autophagy and similar less studied processes when interpreting clinical 














Chapter Four  
Conclusions and Discussion 
The possibility of autophagy as a cell death mechanism has been controversial. 
Notwithstanding the observation of autophagy in dying cells in several species, there has 
been no direct evidence for autophagic cell death. We have shown that L929 cells 
undergo autophagic cell death upon treatment with the pan-caspase inhibitor zVAD-fmk 
(chapter 2).  We have also demonstrated that zVAD induced death can be prevented by 
RNAi inhibition of ATG genes. We have presented evidence of the involvement of the 
MKK7-JNK-cJUN pathway in autophagic cell death. We have also shown that inhibition 
of caspase-8 by RNAi mimics zVAD treatment, suggesting that zVAD induces death 
most likely by inhibiting caspase-8. Our work defines a novel regulatory role for caspase-
8 in suppressing autophagy. Our work has implicated RIP as a possible switch between 
apoptotic and autophagic cell death, and as a potential mediator of the induction of 
autophagy following caspase-8 inhibition. We therefore propose a tentative model to 
explain the role of caspase-8 in autophagy (Fig. 15). 
Our work on autophagy in tumors has demonstrated the presence of autophagic 
structures in several primary cancer tissues (chapter 3), including cancers of the breast 
and lung. These two tumors account for more deaths from cancer than any other type. In 
view of the frequency of resistance to conventional therapy in these cancers and the high 
mortality rate, a therapeutic approach based on enhancing autophagic cell death would be 
expected to have a significant impact. Investigation of the role of autophagy in tumors is 








Fig.15. Model for caspase-8 regulation of autophagy in L929 cells. A. Sequestered 
fraction of caspase 8 is activated at basal states by unknown mechanisms. Active caspase 
8 processes RIP, thereby inactivating it. JNK is not phosphorylated and no autophagy 
ensues. B. When caspase 8 is inhibited, either by zVAD or RNAi, RIP cleavage ceases 
and RIP is free to induce autophagy. The induction involves the MKK7-JNK-cJUN 
























Our model of autophagic death places caspase-8 and RIP at a nodal point in 
normal cellular processes, apoptosis and autophagy. We favor the idea that some caspase-
8 activity is essential for cellular processes. There is evidence that caspases are important 
for proliferation and maturation functions (90, 91). Also, death receptors and caspases 
play a role in the immune response (92, 93, 94). These non-death functions might be 
served by a distinct pool of caspase molecules that are active at basal states. Although 
caspase-8 is classically activated by the death receptor pathway, recent reports suggest 
that an alternative cytosolic compartment may exist in which caspase-8 is activated 
through unknown mechanisms (95, 96). This possibility is enticing as it could also 
explain why caspase-8 is necessary for normal cell function and imply that cells are 
programmed to die in its absence or inhibition. Alternatively, autophagic death might be 
triggered only when death pathways, most likely the death receptor pathway, are 
activated in response to a death stimulus but with caspase-8 activity inhibited due to viral 
inhibitors or mutations in apoptosis genes. TNF stimulation is a possible source of the 
death stimulus as L929 cells synthesize TNF endogenously. TNF addition to L929 cells 
treated with zVAD greatly accelerated death (data not shown). Survival or death might 
also depend on the molecular milieu in the cell in the context of caspase 8 activation (for 
e.g. adaptor molecules like FADD, c-FLIP). Clearly, much remains to be known about 
caspase-adaptor interactions and their effects. 
Caspase-8 homozygous deficient patients are almost entirely normal in 
development and have normal cell populations except for slightly increased blood 
leukocyte levels and some defects in lymphocyte activation and immune response (94). 
We hypothesize that autophagic death, possibly in addition to other non-apoptotic death 
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mechanisms, is responsible for normal programmed cell death during development in 
these patients. Another possibility is that caspase 10, which is functional in these patients, 
could substitute for caspase 8 (97 and see below). L929 mouse cells lack caspase-10, 
possibly allowing caspase-8 inhibition alone to uncover the autophagic pathway. 
Mice deficient in caspase-8 die during embryogenesis with defective myocardial 
development (98). This observation may point to a role for caspase-8 in cell growth and 
differentiation, either directly in the myoblast progenitors or in other tissue cells 
necessary for cell-cell interactions during development. These mice also show fewer 
blood cell precursors in the bone marrow. An absence of caspase-8 in precursor cells 
might cause excessive autophagic death or defective differentiation.  
Data from the caspase-8 RNAi experiments confirm a specific role for caspase-8 
in suppressing autophagy, leading us to believe that inhibition of caspase-8 activity is the 
mode of action of zVAD. Also, inhibition of caspases 1, 2, 3, 9 and 12 did not enhance 
cell death in L929 cells (data not shown). However, it is not possible to completely rule 
out the involvement of another zVAD target. zVAD has been reported to inhibit several 
kinases and kinases are prominently involved in the known regulatory pathways of 
autophagy. An interesting parallel is the efficacy of 3-MA and Wortmannin in blocking 
autophagy by inhibiting PI3K (7). Assay of the activity of kinases presumed to function 
upstream of autophagy might delineate more precisely the targets of zVAD. Obvious 
candidates to be studied would include RIP itself, PI3K, PI3K dependent kinase 1 
(PDK1), Akt, S6 kinase (pp70S6K), DAP-kinase and DRP. Unlike zVAD, other common 
caspase inhibitors (e.g. IETD, zFA, LEHD, DEVD, zAAD) surprisingly do not kill L929 
cells significantly (data not shown). Our experience with pan-caspase inhibitors has 
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shown that zVAD causes the most reduction in caspase 8 activity in L929 cells (data not 
shown). Protein levels and activity levels of caspase 8 in the presence of IETD would 
illuminate the reasons for our negative results with IETD. Also, fibroblasts from mice 
lacking caspase-8 show defective Fas induced cell death (98). Our model would seem to 
require that fibroblasts from caspase 8 deficient mice be sensitive to autophagic killing 
upon Fas activation. We cannot entirely reconcile this conflicting piece of data as of now. 
Repeating the experiments in primary cell cultures from mice fibroblasts and other cell 
types might help in resolving this tricky issue. 
We have some evidence suggesting that RIP is a substrate for caspase-8 and that 
zVAD treatment causes an increase in the amount of full length RIP protein but does not 
completely prevent RIP cleavage (99 and data not shown). The truncated fraction of RIP 
presumably acts as a dominant negative inhibitor of RIP activity. We have also analyzed 
p38MAP kinase and Erk in zVAD-treated L929 cells. Neither showed an appreciable 
effect in either inducing or preventing autophagic cell death. DAP kinase (death 
associated protein kinase) and DRP (DAP kinase related protein) are involved in 
mediating both extrinsic and intrinsic death pathways (100, 101). DAP-kinase and DRP 
also cause formation of plasma membrane blebs during apoptosis (101). Interestingly, 
zVAD treated cells manifest similar membrane blebbing (Fig. 6). We propose to 
investigate the involvement of DAP-kinase and DRP in regulation of the autophagic 
death pathway. Also, inhibition of autophagy by ATG RNAi, while blocking autophagy, 
did not prevent membrane blebbing, suggesting that DAP and DRP kinases, if involved, 
are probably upstream of the Atg proteins or activated independently (Fig. 9 B). 
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We recognize the gaps in our understanding of this mechanism of death, 
especially with regard to two areas. The target molecule of RIP’s kinase activity that 
presumably mediates the autophagy inducing effect is unknown. Experiments to identify 
the substrate are complex due to the large set of potential candidate proteins. Secondly, 
we do not know the mediators that link the MKK7-JNK-cJUN pathway to the Atg 
pathway. Although, the known transcription factor activity of c-JUN and evidence from 
Drosophila salivary gland PCD studies suggest transcriptional control, we cannot confirm 
direct regulation of ATG gene transcription. RT-PCR experiments to quantitate ATG 
transcripts in zVAD treated L929 cells have been inconclusive in this regard.  
We have not analyzed changes in mitochondrial polarization and permeability, the 
activity of the Bcl2 proteins and changes in effector caspases when L929 cells are treated 
with zVAD. Caspase-9 inhibition did not cause cell death and therefore, a primary role 
for the mitochondrial death pathway is unlikely. Given that caspase-8 can cleave Bid, a 
pro-apoptotic Bcl2 protein, to initiate the mitochondrial or intrinsic pathway (102), 
studies to investigate Bid cleavage and mitochondrial function in zVAD induced death 
would be interesting. 
The demonstration of autophagic cell death (chapter 2) suggests a causative role 
in some of the instances in which autophagy is associated with dying cells. Autophagic 
death could underlie the tumor suppressor effect of Atg6 / Beclin-1 (70, 71, 72). So far, 
we have evidence of autophagic cell death in two other cell types namely U937 human 
lymphoblast cells and RAW mouse macrophage cells (data not shown). The universality 
of autophagic cell death remains under investigation. Autophagic cell death might explain 
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several observations of non-apoptotic death in development, viral and bacterial 
infections, neurodegeneration and cancer. 
Development 
The best documented association of autophagy with cell death has been in development 
(31). The presence of an alternate cell death route probably ensures removal of redundant 
cells or impaired cells, a process that is vital for normal organogenesis. Although we have 
no direct evidence implicating the death receptor or  mitochondrial pathway in 
autophagic cell death, input from classical apoptosis inducing pathways to autophagic 
death might indeed exist. It is then tempting to speculate that an extrinsic or intrinsic 
death inducing signal, entrusted with the mission of ensuring proper development, is 
executed through autophagic death when apoptosis fails. The induction of autophagic 
death upon inhibition of apoptotic mechanisms (Fig. 1 C) might explain why, for 
example, Apaf-1 knockout mice which are defective in apoptosis exhibit normal 
development of digital webs (103). 
Infectious diseases 
Certain viruses endeavor to prevent killing of their host cells (infected cells) by cytotoxic 
lymphocytes of the immune system. Different viruses subvert the apoptotic process at 
different points (104). Some viruses (e.g. Cytomegalovirus / CMV) encode for a protein 
called ‘viral inhibitor of caspase’ (vICA) that deactivates caspase 8 (105). We expect 
CMV infected cells to be extremely susceptible to autophagic death based on our model. 
On the contrary, several bacteria (e.g. Brucella abortus, Porphyromonas gingivalis, 
Legionella pneumophila, Leishmania donovani, Coxiella burnetii) and some viruses (e.g. 
Picornavirus) subvert autophagy to facilitate their replication (106, 107, 108). SipB 
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protein from Salmonella enterica  induces autophagic vacuoles and causes cell death in 
host macrophages as part of its pathogenicity, but it is not clear if autophagy directly 
causes the observed cell death (109). Thus, the role of autophagy in the context of viral 
and bacterial infections, as in tumors (chapter 3), remains perplexing. Regulatory 
influences other than caspase-8 are probably modified differently in different situations.  
Neurodegenerative diseases and myopathy 
Autophagic structures have been identified in Huntington’s disease (110), Parkinson’s 
disease (111), Alzheimer’s disease (112) and Creutzfeldt-Jakob disease (113). 
Progressive loss of neurons is characteristic of all these conditions. Autophagic cell death 
might contribute to neurodegeneration, given the frequency of non-apoptotic cell death 
observed in neurons (3). The possibility of autophagic cell death also urges caution in 
developing therapies based on caspase inhibitors to treat neurodegeneration. Certain 
myopathies such as X-linked Myopathy with Excessive Autophagy (XMEA) and 
Infantile Autophagic Vacuolar Myopathy or atypical Danon’s disease exhibit prominent 
autophagic structures (114, 115). As noted above, caspase 8 deficient mice are defective 
in myocardial development. It is possible that autophagic death in the myoblasts or 
myocytes or in adjacent stromal cells may contribute to the pathology of these 
myopathies. 
Cancer 
Inactivation of apoptosis is common in cancer (2, 116), but mutations in caspases have 
not been identified. One possible reason could be that caspase mutations, especially 
caspase 8, in the light of our model, may not confer a survival advantage to the cell. 
Augmentation of autophagic cell death shows promise as a therapeutic approach (chapter 
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3). Rapamycin, an enhancer of autophagy, is being studied in several clinical trials, either 
alone or in combination with other modalities. ATG genes are potentially exciting targets 
for induction of autophagy. Anti-Fas antibodies are under evaluation as chemotherapeutic 
agents. While they are intended to promote apoptosis, they might be expected to enhance 
autophagic death when apoptosis is impaired as is the case in most tumors.  
The mechanism of autophagic death and the evidence for autophagy in primary 
tumors suggest that autophagy functions as a barrier to tumor development. Future work 
to elucidate the complex control of autophagy and autophagic cell death could uncover 
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